p21(Waf1/Cip1/Sdi1) and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 154, Issue 2, 1996, Pages 477-483

  Kuwano, Kazuyoshi ^a   Kunitake, Ritsuko ^a   Kawasaki, Masayuki ^a   Nomoto, Yoshitugu ^a   Hagimoto, Naoki ^a   Nakanishi, Yoichi ^a   Hara, Nobuyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P21; PROTEIN P53; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE;

ADULT; AGED; ARTICLE; BRONCHIOLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA STRAND BREAKAGE; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROSIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; APOPTOSIS; CASE CONTROL STUDY; CHEMISTRY; COMPARATIVE STUDY; DNA DAMAGE; DNA REPAIR; GENETICS; LUNG; LUNG EMPHYSEMA; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR SUPPRESSOR GENE; UPREGULATION;

AGED; APOPTOSIS; CASE-CONTROL STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA DAMAGE; DNA REPAIR; FEMALE; GENES, P53; HUMANS; LUNG; MALE; MIDDLE AGED; PULMONARY EMPHYSEMA; PULMONARY FIBROSIS; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 0030215822     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.154.2.8756825     Document Type: Article

References (35)

1. Crystal, R. G., P. B. Bitterman, S. I. Rennard, A. J. Hance, and B. A. Keogh. 1984. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N. Engl. J. Med. 310:154-166.
2. Khalil, N., R. N. O'Connor, H. W. Unruh, P. W. Warren, K. C. Flanders, A. Kemp, O. H. Bereznay, and A. H. Greenberg. 1991. Increased production and immunohistochemical localization of transforming factor-β in idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 5:155-162.
3. Limper, A. H., T. J. Broekelmann, T. V. Colby, G. Malizia, and J. A. McDonald. 1991. Analysis of local mRNA for extracellular matrix proteins and growth factors using in situ hybridization in fibroproliferative lung disorders. Chest 99:55S-56S.
4. 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Prof. Natl. Acad. Sci. U.S.A. 88:6642-6646.
5. 1 coincides with inhibition of phosphorylation and cytoplasmic translocation of p53 protein. Biochem. Biophys. Res. Commun. 183:1175-1183.
6. Kastan, M. B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R. W. Craig. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:6304-6311.
7. Kuerbitz, S. J., B. S. Plunkett, W. V. Walsh, and M. B. Kastan. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. U.S.A. 89:7491-7495.
8. Lowe, S. W., E. M. Schmitt, S. W. Smith, B. A. Osborne, and T. Jacks. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847-849.
9. Nelson, W. G., and M. B. Kastan. 1994. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14:1815-1823.
10. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
11. Noda, A., Y. Ning, S. F. Venable, O. M. Pereira-Smith, and J. R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell. Res. 211:90-98.
12. El-Deily, W. S., T. Takashi, V. E. Veluculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kintzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
13. El-Deiry, W. S., J. W. Harper, P. M. O'Connor, V. E. Velculescu, C. E. Canman, J. Jackman, J. A. Pietenpol, M. Burrell, D. E. Hill, Y. Wang, K. G. Wiman, W. E. Mercer, M. B. Kastan, K. W. Kohn, S. J. Elledge, K. W. Kintzler, and B. Vogelstein. 1994. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1169-1174.
14. Polunovsky, V. A., B. Chen, C. Henke, D. Snover, C. Wendt, D. H. Ingbar, and P. B. Bitterman. 1993. Role of mesenchymal cell death in lung remodeling after injury. J. Clin. Invest. 92:388-397.
15. Gavrieli, Y., Y. Sherman, and S. A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
16. Shin, R. W., T. Iwaki, T. Kitamoto, and J. Tateishi. 1991. Methods in laboratory investigation. Hydrated autoclave pretreatment enhances TAU. Immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues. Lab. Invest. 64:693-702.
17. Liebow, A. 1975. Definition and classification of interstitial pneumonias in human pathology. In F. Baset and R. George, editors. Progress in Respiration Research, Vol. 8. Karger, New York. 1-33.
18. Panos, R. J., and R. J. Mason. 1991. Hypertrophic alveolar type II cells isolated after silica-induced lung injury are progressing through the cell cycle and maintain a commitment to DNA synthesis in primary culture. Chest 99:27S-28S.
19. Turner-Warwick, M., M. Lebowitz, B. Burrows, and A. Johnson. 1980. Cryptogenic fibrosing alveolitis and lung cancer. Thorax 35:496-499.
20. Tukiainen, P., E. Taskinen, P. Holsti, O. Korhola, and M. Valle. 1983. Prognosis of cryptogenic fibrosing alveolitis. Thorax 38:349-355.
21. Nagai, A., A. Chiyotani, T. Nakadate, and K. Konno. 1992. Lung cancer in patients with idiopathic pulmonary fibrosis. Tohoku J. Exp. Med. 167:231-237.
22. Antoniades, H. N., T. Galanopoulos, J. Neville-Golden, C. P. Kitritsy, and S. E. Lynch. 1994. p53 expression during normal tissue regeneration in response to acute cutaneous injury in swine. J. Clin. Invest. 93:2206-2214.
23. Michieli, P., M. Chedid, D. Lin, J. H. Pierce, W. E. Mercer, and D. Givol. 1994. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54:3391-3395.
24. Wahl, S. M. 1985. Host immune factors regulating fibrosis. In D. Evered and J. Whera, editors. Fibrosis, Vol. 114. Ciba Foundation Symposium, Pittman, London. 175-195.
25. Lacronique, J. G., S. S. Rennard, P. B. Bitterman, T. Ozaki, and R. G. Crystal. 1984. Alveolar macrophages in idiopathic pulmonary fibrosis have glucocorticoid receptors, but glucocorticoid therapy does not suppress alveolar macrophage release of fibronectin and alveolar macrophage-derived growth factor. Am. Rev. Respir. Dis. 130:350-356.
26. Martinet, Y., W. N. Rom, G. R. Grotendorst, G. R. Martin, and R. G. Crystal. 1987. Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 317:202-209.
27. Xiong, Y., H. Zhang, and D. Beach. 1993. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev. 7:1572-1583.
28. Xiong, Y., H. Zhang, and D. Beach. 1992. D-type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71:505-514.
29. Waga, S., G. J. Hannon, D. Beach, and B. Stillman. 1994. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574-578.
30. Terzaghi, M., P. Nettesheim, and M. L. Williams. 1978. Re-population of denuded tracheal grafts with normal, pre-neoplastic and neoplastic epithelial cell populations. Cancer Res. 38:4546-4553.
31. Adamson, I. Y. R., L. Young, and D. H. Bowden. 1988. Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am. J. Pathol. 130:377-383.
32. Li, C. Y., L. Suardet, and J. B. Little. 1995. Potential role of WAF1/Cip1/p21 as a mediator of TGF-β cytoinhibitory effect. J. Biol. Chem. 270:4971-4974.
33. Kip1 a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66.
34. Toyoshima, H., T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67-74.
35. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8:9-22.